<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-biomolecules-10-01625">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xianfeng</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vincent</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Fernando</surname>
    <given-names>L.R.</given-names>
   </name>
   <name>
    <surname>Wai</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Yvonne</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Mak</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Weimin</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yasheen</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Eric</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>Jacob</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</article-title>
  <source>J. Med. Chem.</source>
  <year>2017</year>
  <volume>60</volume>
  <fpage>8011</fpage>
  <lpage>8026</lpage>
  <pub-id pub-id-type="pmid">28953378</pub-id>
 </element-citation>
</ref>
